The Hessen-based company offers specialty reagents for research and development, diagnostics, and drug discovery in the transglutaminase field. Zedira's products include TG6, a neuronal transglutaminase marker used to detect neurological disorders caused by gluten, as well as proteases, assays, substrates, antibodies, inhibitors, and autoantibody detection ELISA-Kits. The company also develops small molecular drug candidates and engages in the discovery of small molecules that block dysregulated transglutaminases. Zedira's services assist investigators studying celiac disease and enable doctors to reduce the life-threatening tendency to bleeding.